AFRICA – Africa Centres for Disease Control and Prevention (Africa CDC), a public health agency of the African Union, has partnered with pharmaceutical corporation Pfizer to supply the firm’s antiviral…
Read MoreTag: Molnupiravir
Generic manufacturers in developing countries licensed to make Merck’s COVID-19 pill
SWITZERLAND – The Medicines Patent Pool (MPP) has announced that it has signed contracts with 27 manufacturers to manufacture Merck’s COVID-19 pill. MPP’s agreements with generic manufacturers cover the production…
Read MoreOmicron vaccine to be ready in March, says Pfizer CEO
USA – Pfizer CEO, Albert Bourla has said that the company expects a Covid-19 vaccine targeting the Omicron variant to be ready in March. Albert Bourla told CNBC that the…
Read MorePfizer scores another Paxlovid deal with the US government
USA – The United States has increased its order for Pfizer’s COVID-19 antiviral Paxlovid from 10 million to 20 million courses, the company has announced. With two COVID-fighting antiviral pills…
Read MoreMerck, Thermo Fisher in pact to manufacture oral COVID-19 pill in Canada
CANADA – Merck & Co has announced a deal with Thermo Fisher Scientific to manufacture its experimental COVID-19 pill at the medical device maker’s Whitby, Ontario facility, according to Reuters…
Read MorePfizer plans to ramp up antiviral pill production in fight against Omicron variant
USA – Pfizer CEO, Albert Bourla has confirmed the company’s plans to increase production of its Paxlovid antiviral treatment in order to combat the spread of the new Omicron variant.…
Read MoreBayer, Dr. Reddy’s settle patent row over cancer drug Nexavar
GERMANY – Bayer Healthcare and Amgen subsidiary Onyx Pharmaceuticals have agreed to drop their patent lawsuit against Dr. Reddy’s Laboratories over the proposed generic version of Nexavar. According to a…
Read MorePfizer, US ink US$ 5.29 billion deal for Covid pill
USA – Pfizer Inc has announced that the US government will pay US$5.29 billion for 10 million courses of its experimental COVID-19 antiviral drug, as the country seeks promising oral…
Read MorePfizer applies for emergency use authorization of its novel COVID-19 pill
USA – Pfizer, a US-based pharmaceutical giant has asked the Food and Drug Administration to approve its experimental COVID-19 pill for emergency use, setting the stage for a likely launch…
Read MoreRoche terminates partnership to develop COVID-19 pill with Atea
SWITZERLAND – Roche Holding AG has terminated its collaboration with Atea Pharmaceuticals Inc.to develop a COVID-19 antiviral pill, the Swiss drugmaker has announced. The partnership termination has happened a month…
Read More